How Bubonic Plague Reshaped The Streets Of Mumbai wksu.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wksu.org Daily Mail and Mail on Sunday newspapers.
Delhi MCD bypoll vote-counting begins
The ruling Bharatiya Janata Party (BJP) in Assam, which on Friday announced its first list of 70 candidates for the first two phases of Assembly elections in the state, has given tickets to two former Congress ministers, 11 new faces and three Muslim candidates.
Former Congress ministers Ajanta Neog and Gautam Roy got BJP tickets to contest from their old seats of Golaghat and Katighora, respectively. Neog and Gowala had joined the saffron party in December last year.
Former Congress legislator Rajdeep Gowala, who was elected to the Assembly after winning in the 2016 elections from Lakhipur, has been denied a ticket by the BJP this time.
UNICEF, the UN's Children's Fund, says schools for more than 168 million children have been shuttered entirely by the coronavirus pandemic, with countries in the Caribbean and Latin America among the worst affected.
USA TODAY
An advisory committee voted unanimously Friday to recommend authorizing a COVID-19 vaccine from Johnson & Johnson for use in adults, paving the way for an expected Food and Drug Administration authorization within the next few days.
Johnson & Johnson agreed to provide 100 million doses of its single-shot vaccine in the U.S. by June, including 20 million by the end of March. Those doses will add to the 300 million doses Pfizer-BioNTech and Moderna each have promised to deliver by the end of July.
The vaccine was shown to be 72% effective in a U.S. trial in which all ethnic, racial and age groups benefited about the same, and was shown to be 85% effective in preventing the most severe disease.
An advisory committee voted unanimously Friday to recommend authorizing a COVID-19 vaccine from Johnson & Johnson for use in adults, paving the way for an expected Food and Drug Administration authorization within the next few days.
Johnson & Johnson agreed to provide 100 million doses of its single-shot vaccine in the U.S. by June, including 20 million by the end of March. Those doses will add to the 300 million doses Pfizer-BioNTech and Moderna each have promised to deliver by the end of July.
The vaccine was shown to be 72% effective in a U.S. trial in which all ethnic, racial and age groups benefited about the same, and was shown to be 85% effective in preventing the most severe disease.